Salivary Esterase Activity and Its Association with the Biodegradation of Dental Composites

Pseudocholinesterase (PCE) and cholesterol esterase (CE) can hydrolyze bisphenylglycidyl dimethacrylate (bisGMA) and triethylene glycol dimethacrylate (TEGDMA) monomers. This study will test the hypothesis that enzyme activities showing CE and PCE character are found in human saliva at levels sufficient to hydrolyze ester-containing composites important to restorative denstistry. The study also seeks to ask if the active sites of CE and PCE with respect to composite could be inhibited. Photo-polymerized model composite resin was incubated in PCE and CE solutions, in the presence and absence of a specific esterase inhibitor, phenylmethylsulfonyl fluoride (PMSF). Incubation solutions were analyzed for resin degradation products by high-performance liquid chromatography (HPLC), UV spectroscopy, and mass spectrometry. Saliva was found to contain both hydrolase activities at levels that could degrade composite resins. PMSF inhibited the composite degradation, indicating a material hydrolysis mechanism similar to the enzymes’ common function.

[1]  C. Nord,et al.  Origin of esterases in human whole saliva. , 1977, Enzyme.

[2]  O. Hanninen,et al.  Pseudocholinesterase Activity and Its Origin in Human Oral Fluid , 1983, Journal of dental research.

[3]  R. Ryhänen.  Pseudocholinesterase activity in some human body fluids. , 1983, General pharmacology.

[4]  D. Quinn,et al.  Dimensional mapping of the active site of cholesterol esterase with alkylboronic acid inhibitors. , 1990, Biochimica et biophysica acta.

[5]  D. Hui,et al.  Modified Low Density Lipoprotein Enhances the Secretion of Bile Salt-stimulated Cholesterol Esterase by Human Monocyte-Macrophages , 1997, The Journal of Biological Chemistry.

[6]  P. Spencer,et al.  Phenyl-n-butylborinic acid is a potent transition state analog inhibitor of lipolytic enzymes. , 1986, Biochemical and biophysical research communications.

[7]  R. Page,et al.  Histopathologic features of the initial and early stages of experimental gingivitis in man. , 1975, Journal of periodontal research.

[8]  J. Santerre,et al.  Model systems to assess the destructive potential of human neutrophils and monocyte-derived macrophages during the acute and chronic phases of inflammation. , 2001, Journal of biomedical materials research.

[9]  D. Hui,et al.  Molecular recognition by cholesterol esterase of active site ligands: structure-reactivity effects for inhibition by aryl carbamates and subsequent carbamylenzyme turnover. , 1996, Biochemistry.

[10]  J. Santerre,et al.  The enzymatic hydrolysis of a synthetic biomembrane: a new substrate for cholesterol and carboxyl esterases. , 1994, Journal of biomaterials science. Polymer edition.

[11]  S. Froelich,et al.  Cholesterol esterase catalyzed hydrolysis of mixed micellar thiophosphatidylcholines: a possible charge-relay mechanism. , 1991, Biochemistry.

[12]  H. Chauncey.  Salivary enzymes. , 1961, Journal of the American Dental Association.

[13]  N. Yamalık,et al.  Determination of Pseudocholinesterase Activity in the Gingival Crevicular Fluid, Saliva, and Serum from Patients with Juvenile Periodontitis and Rapidly Progressive Periodontitis , 1990, Journal of dental research.

[14]  R. Kisilevsky,et al.  Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse. , 1997, Biochimica et biophysica acta.

[15]  R. Smith,et al.  The stability of methacrylate biomaterials when enzyme challenged: kinetic and systematic evaluations. , 2001, Journal of biomedical materials research.

[16]  J. Santerre,et al.  Interactions between resin monomers and commercial composite resins with human saliva derived esterases. , 2002, Biomaterials.

[17]  F. Williams.  Clinical Significance of Esterases in Man , 1985, Clinical pharmacokinetics.

[18]  R. Labow,et al.  Porcine cholesterol esterase, a multiform enzyme. , 1983, Biochimica et biophysica acta.

[19]  O. Koulouri,et al.  Relative proportions of mononuclear cell types in periodontal lesions analyzed by immunohistochemistry. , 1999, Journal of clinical periodontology.

[20]  J. Slots,et al.  Salivary enzymes. Origin and relationship to periodontal disease. , 1983, Journal of periodontal research.

[21]  J. Santerre,et al.  Relation of dental composite formulations to their degradation and the release of hydrolyzed polymeric-resin-derived products. , 2001, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[22]  H. Shintani,et al.  Residual monomers (TEGDMA and Bis-GMA) of a set visible-light-cured dental composite resin when immersed in water. , 1991, Journal of oral rehabilitation.

[23]  N. Yamalık,et al.  The Effect of Periodontal Therapy on Salivary Pseudocholinesterase Activity , 1991, Journal of dental research.

[24]  J. Santerre,et al.  Effect of filler content on the profile of released biodegradation products in micro-filled bis-GMA/TEGDMA dental composite resins. , 1999, Biomaterials.

[25]  J. Santerre,et al.  Biodegradation of a dental composite by esterases: dependence on enzyme concentration and specificity , 2003, Journal of biomaterials science. Polymer edition.

[26]  J. Santerre,et al.  Biodegradation of Commercial Dental Composites by Cholesterol Esterase , 1999, Journal of dental research.

[27]  M. Freund,et al.  Enzymatic hydrolysis of (di)methacrylates and their polymers. , 1990, Scandinavian journal of dental research.